CHICAGO, Feb. 06, 2018 -- Lumere, the leading provider of data-driven analytics, evidence and expert guidance to help health systems reduce unnecessary clinical variation and costs, today announced the appointment of John Cherf, MD, MPH, MBA, as the company’s first-ever chief medical officer (CMO).
A practicing orthopedic surgeon with over 20 years of clinical and healthcare leadership experience, Dr. Cherf has published in numerous peer review journals, speaks internationally and has served as an advisor and consultant to several orthopedic and healthcare businesses and organizations, including the FDA. He will play a vital role in shaping Lumere’s solutions and services focusing on drug and device selection and utilization.
"We're excited about the combination of clinical and change management experience that Dr. Cherf brings to our team," said Lumere CEO Hani Elias, JD, MPH. "He is an experienced clinical leader who understands the unique needs and concerns of physicians and can share that understanding with our clients. Because Dr. Cherf continues to practice, he brings practical experience as well as a keen awareness of the state of healthcare and the wide range of available drugs and devices."
In his role as CMO, Dr. Cherf will oversee Lumere’s Physician Advisory Council, which provides practical, field-based insights to support the firm’s data-driven solutions. “I see tremendous opportunity within healthcare to use clinical evidence to drive better performance, both financially and clinically,” he said. “Lumere’s data-driven approach to decision making is grounded in evidence rather than subjective experiences. That resonates with physicians I speak to and opens new doors to cross-departmental collaboration. The foundation that Lumere has developed has the opportunity to drive transformational change.”
Dr. Cherf also continues his private practice and serves as the chief of orthopedics for Chicago-based Advocate Illinois Masonic Medical Center. He previously served as the chief medical officer for Pinpoint Care, chairman of OrthoCentrix Solutions, and the president of OrthoIndex. He attended the Northwestern University Feinberg School of Medicine for his MD where he also obtained a Masters’ in Public Health (MPH). He received his Masters’ of Business Administration (MBA) from Northwestern University’s Kellogg School of Management.
About Lumere
Lumere is at the forefront of clinical decision making for drugs and devices, offering evidence-based solutions and services for all providers that improve care and reduce cost across the patient journey. For more information, visit Lumere.com, find us on LinkedIn, follow @LumereHQ on Twitter and like us on Facebook.
Media Contacts
Pam Flores
[email protected]
773-218-9260


Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Instagram Outage Disrupts Thousands of U.S. Users
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 



